Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery
May 24th, 2021
7.8K views
Different models of middle cerebral artery occlusion (MCAo) are used in experimental stroke research. Here, an experimental stroke model of transient MCAo via the external carotid artery (ECA) is described, which aims to mimic human stroke, in which the cerebrovascular thrombus is removed due to spontaneous clot lysis or therapy.
Overview
This article demonstrates a standardized mouse model of transient middle cerebral artery occlusion (MCAo) using the filament technique. The model enables complete restoration of cerebral blood flow upon filament removal, closely simulating therapeutic or spontaneous clot lysis in human stroke. The protocol details surgical steps, monitoring, and functional analysis, aiming to improve reproducibility in experimental stroke research.
Key Study Components
Area of Science
- Neuroscience
- Stroke research
- Experimental models
Background
- Stroke is a leading cause of mortality and adult disability in developed countries.
- Therapeutic options are limited to a small subset of patients within hours after stroke onset.
- Research focuses on extending the therapeutic window and understanding post-stroke mechanisms such as inflammation, angiogenesis, and neuronal regeneration.
- Reproducibility issues in preclinical stroke research highlight the need for standardized models.
Purpose of Study
- To provide a detailed, standardized protocol for the filament-based MCAo mouse model.
- To facilitate reproducible induction and analysis of transient focal cerebral ischemia.
- To simulate human stroke conditions, including reperfusion after vessel occlusion.
Methods Used
- Transient occlusion of the middle cerebral artery in mice using an intraluminal filament.
- Continuous monitoring of cerebral blood flow with a laser Doppler probe.
- Surgical preparation including anesthesia, temperature control, and careful dissection of carotid arteries.
- Assessment of neurological deficits and infarct volume using neurobehavioral scoring and cresol violet staining of brain sections.
Main Results
- The model achieves complete reperfusion of the brain after filament removal, mimicking successful mechanical thrombectomy in humans.
- Stroke animals showed significant changes in composite and focal neuro scores compared to sham controls.
- Infarct volume averaged 61–62 mm2, representing 48% of the affected hemisphere, involving cortex and subcortical structures.
- Proper surgical technique, especially careful dissection to avoid nerve damage, is critical for model success.
Conclusions
- The standardized filament MCAo model enables reproducible induction of transient focal cerebral ischemia in mice.
- It closely replicates key aspects of human stroke, including reperfusion injury.
- This protocol supports improved reproducibility and comparability in preclinical stroke research.
Frequently Asked Questions
What are the main advantages of the filament MCAo model over other stroke models?
The filament model does not require craniotomy and allows for complete reperfusion of the occluded vessel, closely simulating human stroke with vessel recanalization.
How is cerebral blood flow monitored during the procedure?
Cerebral blood flow is continuously monitored using a laser Doppler probe placed over the middle cerebral artery territory.
What are the key steps to ensure reproducibility in this model?
Careful dissection of the carotid arteries, precise filament placement, and consistent monitoring of blood flow are essential for reproducibility.
How is infarct volume assessed in this protocol?
Infarct volume is measured using cresol violet staining of coronal brain sections 24 hours after stroke induction.
What neurological assessments are performed on the mice?
Composite and focal neuro scores are used to evaluate neurological deficits post-stroke, with significant changes observed in stroke animals compared to shams.
How does this model relate to human stroke treatment?
The model simulates the restoration of blood flow seen after successful mechanical thrombectomy or spontaneous clot lysis in human stroke patients.
What postoperative care is provided to the animals?
Animals receive analgesia every 12 hours for three days, wet food, hydrogel, and are kept in a temperature-controlled environment to support recovery.
Executive Industry Relevance
Standardized modeling of transient middle cerebral artery occlusion (MCAo) in mice addresses a critical need for reproducible preclinical stroke research. This model enables rigorous evaluation of therapeutic hypotheses targeting post-stroke mechanisms and supports translational continuity by simulating reperfusion events observed in human stroke interventions. Its reproducibility and quantitative outputs strengthen predictive confidence at the early discovery and preclinical inflection points.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of pathophysiological pathways such as inflammation, angiogenesis, and neuronal regeneration post-stroke.
- Supports biological de-risking by providing a controlled, reproducible model for functional target validation.
- Facilitates predictive confidence in therapeutic hypothesis testing and portfolio triage for stroke-related targets.
Screening & Assay Development
- Prepares validated, standardized in vivo systems for downstream efficacy and mechanistic screening of candidate compounds.
- Delivers reproducible, quantitative neurobehavioral and infarct volume readouts for assay standardization.
- Enables reliable evaluation of intervention effects on cerebral blood flow and neurological outcomes.
Translational & Preclinical Research
- Aligns with disease-relevant mechanisms by modeling reperfusion injury and neurofunctional deficits seen in human stroke.
- Provides continuity from discovery through preclinical validation by supporting biomarker and outcome measure alignment.
- Informs risk-adjusted advancement decisions for stroke therapeutics based on robust, translationally relevant data.
Pipeline & Workflow Integration
This standardized MCAo model integrates from early discovery through lead identification to preclinical validation in cerebrovascular research pipelines.
- Discovery Biology: Supports hypothesis testing and mechanistic de-risking by enabling controlled induction and reversal of cerebral ischemia.
- Screening: Provides reproducible, quantitative neurobehavioral and infarct volume outputs for compound evaluation.
- Analytics: Delivers continuous cerebral blood flow measurements and standardized scoring for cross-condition comparison.
- Translational Research: Models clinically relevant reperfusion and functional outcomes, supporting biomarker alignment.
- Enterprise Reuse: Establishes a reusable, consortium-standardized platform for stroke research and therapeutic evaluation.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in stroke target validation.
- Operational Value: Enhances reproducibility, standardization, and scalability across research teams.
- Strategic Value: Improves go/no-go decision quality and capital efficiency by reducing late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of stroke therapeutic candidates.
Implementation Considerations
- Requires surgical expertise in vascular dissection and filament placement to avoid nerve damage and ensure model fidelity.
- Needs instrumentation for anesthesia, temperature control, and continuous laser Doppler blood flow monitoring.
- Demands strict cross-team standardization of surgical and analytical procedures for reproducibility.
- Adaptation across mouse strains or comorbidity models may require protocol optimization.
- Careful postoperative care and monitoring are essential for animal welfare and data integrity.
Biopharma FAQs
Why is null hypothesis testing critical in MCAo target validation?
Null hypothesis testing using standardized MCAo models enables objective assessment of intervention effects on infarct volume and neurobehavioral outcomes, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation improve discovery in the filament MCAo procedure?
Precise control of occlusion and reperfusion variables in the filament MCAo model allows isolation of specific intervention effects, enhancing mechanistic clarity and supporting reliable hypothesis testing in the discovery pipeline.
What do quantitative neuro score and infarct volume measurements enable?
Quantitative neurobehavioral scoring and infarct volume analysis provide standardized, reproducible endpoints for comparing experimental groups, enabling data-driven advancement decisions and cross-study benchmarking.
Why are replication requirements essential for cross-functional stroke research?
Replication using detailed, standardized MCAo protocols ensures reproducibility across research teams, facilitating cross-functional collaboration and increasing confidence in preclinical findings for portfolio progression.
What statistical analysis capabilities are needed before implementing MCAo model data?
Robust statistical analysis of neurobehavioral and infarct volume data is required to validate significance, control for variability, and support translational decision-making prior to advancing therapeutic candidates.
Chapters in this video
0:04
Introduction
0:52
Preparation of the Material and Instruments
1:33
Preparation of the Laser Doppler
2:27
Transient MCAo Model (Occlusion)
4:31
Transient MCAo Model (Reperfusion)
6:00
Results: Neuroscore and Volumetric Infarct Analysis After tMCAo
6:54
Conclusion
